Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics is listed as a related topic.
    Difference
    0.2%
    Check dated 2026-03-05T11:13:18.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Removed Melanoma and related topics (MedlinePlus Genetics) from the Related Topics section. This primarily affects navigation and context without changing the study details.
    Difference
    0.2%
    Check dated 2026-02-26T05:55:37.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Melanoma and related topics MedlinePlus Genetics were added, and the revision label was updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-11T23:42:32.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision added: v3.4.1. Melanoma and MedlinePlus Genetics were removed from related topics, along with the Revision: v3.4.0 entry.
    Difference
    0.2%
    Check dated 2026-02-04T22:58:57.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added a glossary and related topic links (Melanoma and MedlinePlus Genetics) and updated revision metadata (Last Update Submitted that Met QC Criteria and Revision: v3.4.0). Removed older QC labels (Last Update Submitted that met QC Criteria, No FEAR Act data) and the prior revision version (v3.3.4).
    Difference
    0.4%
    Check dated 2026-01-28T21:53:02.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 in the footer. Removed Melanoma and the related topic MedlinePlus Genetics, and removed Revision: v3.3.3 from the related topics.
    Difference
    0.2%
    Check dated 2026-01-14T04:17:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.